Build your base

Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula euripidis, hinc partem ei est.
Back to top

Archive

New Horizon /  (Page 4)

I am an Associate Professor in Neonatology at the Department of Paediatrics and Child Health, University of Stellenbosch with an interest in neonatal infectious diseases and the pharmacology of anti-infective agents. I am an active member of the NIH-funded IMPAACT network and the European PENTA network where I lead and collaborate on different pharmacokinetic studies including neonates with TB, HIV and other bacterial infections. In 2021, I was invited to become a member of the WHO Pediatric AIDS Working Group and the Clinical Pharmacology Working Group within PENTA....

Elly Barry is a board-certified pediatrician and pediatric hematologist/oncologist with over 15 years of experience in drug development, currently serving as the Senior Vice President and Head of Clinical Development at Day One Biopharmaceuticals, a company focused on developing medicines for childhood and adult cancers and other rare diseases. Prior to Day One, Elly worked for 7-years at Pfizer as the Global Clinical Lead for Pediatric Oncology and head of the Pfizer’s Pediatric Oncology Leadership Team, overseeing pediatric oncology clinical development and responsible for developing and implementing strategy and deliverables related to pediatric oncology development plans. Elly received her MD degree from Yale University School of Medicine in New Haven, before completing residency training in pediatrics at Tufts-New England Medical Center/Floating...

Krithika joined Certara in 2021, having previously been an Oncology Clinical Pharmacology Reviewer at the FDA for 3 years where she contributed to scientific review of numerous regulatory submissions across all phases from INDs to BLA/NDA submissions. Prior to that, Krithika was at Novartis for 3.5 years where she focused on the DMPK and early clinical development of biologics. Krithika has a degree in Pharmacy from the Birla Institute of Technology and Science (BITS) in Pilani India, and a PhD in Pharmaceutical Sciences from the State University of New York in Buffalo, US....

Lawyer specialised in european health law and bioethics and former Professor at Aix-Marseille University Annagrazia ALTAVILLA is the Chair of TEDDY Network (European Network for paediatric research). She is responsible of International Relations of Espace Éthique PACA-Corse (APHM/AixMarseille University – France). She is consultant/expert of the Council of Europe within its Strategic Action Plan on human rights and technologies in biomedicine (2020-2025) in charge of the Guide on children participation in decision making process in health and of the COE-EU project CP4Europe (ChildrenParticipation4Europe). Former member of the European Medicine Agency (EMA) Paediatric Committee (PDCO), Annagrazia ALTAVILLA is expert/legal advisor of several EU/IMI founded projects. French representative in the board of Directors of the European Association of Health Law, Annagrazia ALTAVILLA is author...

Neil Sebire, MB BS, BClinSci MD, FRCR, FRCOG, FRCPath, FFFCI Prof Sebire is a clinical academic who is Professor of Pathology at Great Ormond Street Hospital for Children/UCL, and chief research information officer at the organisation.  For the past three years he was the inaugural national chief clinical data officer at Health Data Research UK, with a major role in establishing standards for healthcare data interoperability for secondary research use.  He runs the GOSH clinical-informatics research program which includes more than 15 Ph.D. students in various areas of clinical-informatics.  He has a particular interest in real world and pragmatic issues relating to health data and informatics.  He is an established highly cited researcher with >800 peer reviewed scientific publications (H-index 98,...

Dr Brian Aylward is Chair of The Paediatric Committee of the European Medicines, and also has been Chair of the Formulations Working Group of the PDCO since 2014. Prior to his appointment to the PDCO, he was a member of the Clinical Trials Facilitation Group at the Heads of Medicines Agencies (HMA). Brian joined the Health Products Regulatory Authority (HPRA) in Ireland in 2008, before which he practiced as an anaesthesiologist and intensive care medicine physician....